Literature DB >> 22895429

Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Bryce D Smith1, Rebecca L Morgan, Geoff A Beckett, Yngve Falck-Ytter, Deborah Holtzman, Chong-Gee Teo, Amy Jewett, Brittney Baack, David B Rein, Nita Patel, Miriam Alter, Anthony Yartel, John W Ward.   

Abstract

Hepatitis C virus (HCV) is an increasing cause of morbidity and mortality in the United States. Many of the 2.7-3.9 million persons living with HCV infection are unaware they are infected and do not receive care (e.g., education, counseling, and medical monitoring) and treatment. CDC estimates that although persons born during 1945-1965 comprise an estimated 27% of the population, they account for approximately three fourths of all HCV infections in the United States, 73% of HCV-associated mortality, and are at greatest risk for hepatocellular carcinoma and other HCV-related liver disease. With the advent of new therapies that can halt disease progression and provide a virologic cure (i.e., sustained viral clearance following completion of treatment) in most persons, targeted testing and linkage to care for infected persons in this birth cohort is expected to reduce HCV-related morbidity and mortality. CDC is augmenting previous recommendations for HCV testing (CDC. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998;47[No. RR-19]) to recommend one-time testing without prior ascertainment of HCV risk for persons born during 1945-1965, a population with a disproportionately high prevalence of HCV infection and related disease. Persons identified as having HCV infection should receive a brief screening for alcohol use and intervention as clinically indicated, followed by referral to appropriate care for HCV infection and related conditions. These recommendations do not replace previous guidelines for HCV testing that are based on known risk factors and clinical indications. Rather, they define an additional target population for testing: persons born during 1945-1965. CDC developed these recommendations with the assistance of a work group representing diverse expertise and perspectives. The recommendations are informed by the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework, an approach that provides guidance and tools to define the research questions, conduct the systematic review, assess the overall quality of the evidence, and determine strength of the recommendations. This report is intended to serve as a resource for health-care professionals, public health officials, and organizations involved in the development, implementation, and evaluation of prevention and clinical services. These recommendations will be reviewed every 5 years and updated to include advances in the published evidence.

Entities:  

Mesh:

Year:  2012        PMID: 22895429

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  430 in total

1.  Survey of US Correctional Institutions for Routine HCV Testing.

Authors:  Curt G Beckwith; Ann E Kurth; Lauri Bazerman; Liza Solomon; Emily Patry; Josiah D Rich; Irene Kuo
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

2.  Transitioning to highly effective therapies for the treatment of chronic hepatitis C virus infection: a policy statement and implementation guideline.

Authors:  Daniel John Smyth; Duncan Webster; Lisa Barrett; Mark MacMillan; Lisa McKnight; Frank Schweiger
Journal:  Can J Gastroenterol Hepatol       Date:  2014-11

Review 3.  Hepatitis C virus: an overview for dental health care providers.

Authors:  R Monina Klevens; Anne C Moorman
Journal:  J Am Dent Assoc       Date:  2013-12       Impact factor: 3.634

Review 4.  Hepatitis C virus in pregnancy.

Authors:  Mona R Prasad; Jonathan R Honegger
Journal:  Am J Perinatol       Date:  2013-02-06       Impact factor: 1.862

5.  Prevalent and incident hepatitis C virus infection among HIV-infected men who have sex with men engaged in primary care in a Boston community health center.

Authors:  Shikha Garg; Lynn E Taylor; Chris Grasso; Kenneth H Mayer
Journal:  Clin Infect Dis       Date:  2013-02-05       Impact factor: 9.079

6.  Acetaminophen receipt among HIV-infected patients with advanced hepatic fibrosis.

Authors:  E Jennifer Edelman; Kirsha S Gordon; Vincent Lo Re; Melissa Skanderson; David A Fiellin; Amy C Justice
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-09-22       Impact factor: 2.890

7.  Hepatitis C virus testing perspectives among primary care physicians in four large primary care settings.

Authors:  Amy Jewett; Arika Garg; Katherine Meyer; Laura Danielle Wagner; Katherine Krauskopf; Kimberly A Brown; Jen-Jung Pan; Omar Massoud; Bryce D Smith; David B Rein
Journal:  Health Promot Pract       Date:  2014-04-28

8.  Chronic hepatitis C in Western Canada: a survey of practice patterns among gastroenterologists in Alberta and British Columbia.

Authors:  Rohit Pai; Alnoor Ramji; Samuel S Lee; Winnie W Wong; Eric M Yoshida
Journal:  Can J Gastroenterol Hepatol       Date:  2013-11-08

Review 9.  Enhancing our understanding of current therapies for hepatitis C virus (HCV).

Authors:  Neliswa A Gogela; Ming V Lin; Jessica L Wisocky; Raymond T Chung
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

10.  Improvements in brain and behavior following eradication of hepatitis C.

Authors:  Taylor Kuhn; Philip Sayegh; Jacob D Jones; Jason Smith; Manoj K Sarma; A Ragin; Elyse J Singer; M Albert Thomas; April D Thames; Steven A Castellon; Charles H Hinkin
Journal:  J Neurovirol       Date:  2017-05-30       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.